CN Patent

CN109384774B — 一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2023-02-17 · 3y expired

What this patent protects

本发明公开了一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用，该多取代的吡嗪/三嗪酰胺类化合物的结构如通式I所示，各取代基的定义如说明书和权利要求书所述。本发明的多取代的吡嗪/三嗪酰胺类化合物具有卓越的AXL抑制活性，能够用作AXL抑制剂。

USPTO Abstract

本发明公开了一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用，该多取代的吡嗪/三嗪酰胺类化合物的结构如通式I所示，各取代基的定义如说明书和权利要求书所述。本发明的多取代的吡嗪/三嗪酰胺类化合物具有卓越的AXL抑制活性，能够用作AXL抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN109384774B
Jurisdiction
CN
Classification
—
Expires
2023-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Materia Medica of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.